Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

  title={Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.},
  author={Badar M. Mian and Nishin Anil Bhadkamkar and Joel W. Slaton and Peter W. T. Pisters and Danai D. Daliani and David W. Swanson and Louis Pisters},
  journal={The Journal of urology},
  volume={167 1},
PURPOSE Sarcomatoid renal cell carcinoma often has an aggressive clinical course characterized by rapid disease progression. We evaluate prognostic factors for patient survival and the effect of treatment on patient outcome. MATERIALS AND METHODS Between 1987 and 1998, 108 patients were classified as having sarcomatoid renal cell carcinoma at our institution. We reviewed the records of these patients to identify clinical and pathological prognostic variables. The Kaplan-Meier method was used… CONTINUE READING
Highly Cited
This paper has 127 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 62 extracted citations

Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma

Journal of Cancer Research and Clinical Oncology • 2014
View 8 Excerpts
Highly Influenced

Carcinomes rénaux à contingent sarcomatoïde

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie • 2013
View 6 Excerpts
Highly Influenced

Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component

Journal of Cancer Research and Clinical Oncology • 2013
View 9 Excerpts
Highly Influenced

Sarcomatoid differentiation in renal cell carcinoma: prognostic implications

International braz j urol : official journal of the Brazilian Society of Urology • 2005
View 4 Excerpts
Highly Influenced

127 Citations

Citations per Year
Semantic Scholar estimates that this publication has 127 citations based on the available data.

See our FAQ for additional information.